More than 11,000 bottles of blood pressure medication are being recalled nationwide due to a manufacturing defect, according to the Food and Drug Administration.
The 11,460 bottles of chlorthalidone tablets, USP, 25 mg, are being recalled because of “failed dissolution specifications.”
Dissolution tests measure the release rate of a drug and its active ingredient from the tablet or capsule used as a dosage when it’s placed into a liquid to assess the performance and quality of various drug formulations and batches, according to pharmaceutical company Pion.
The recalled drugs were manufactured by Inventia Healthcare Limited of India – which initiated the voluntary recall – and distributed in the U.S. by Rising Pharma Holdings of East Brunswick, New Jersey.
500K PACKAGES OF MACARONI AND CHEESE SOLD AT ALDI RECALLED OVER UNDECLARED SOY LECITHIN
FOX Business reached out to Inventia Healthcare and Rising Pharma for comment.
The Cleveland Clinic said that chlorthalidone is used to treat high blood pressure by helping kidneys remove fluid and salt from a user’s blood through their urine.
It’s considered a diuretic drug and may also be used to reduce swelling related to heart, kidney or liver disease.
DEADLY LISTERIA OUTBREAK SPARKS EXPANDED CHEESE RECALL ACROSS MULTIPLE STATES
The recall was initiated voluntarily by the company on June 5 and is ongoing, according to the FDA’s recall page.
It covers 25 mg chlorthalidone tablets sold in either 100 or 1000 tablets per bottle as prescribed by a doctor.
CDC URGES PARENTS TO STOP USING NARA ORGANICS INFANT FORMULA AFTER THREE BABIES HOSPITALIZED WITH BOTULISM
The 100 tablet bottles covered by the recall have a batch code of RISA24001, while the 1000 tablet bottles have a batch code of RISB24002.
The expiration date for bottles covered by the recall is April 2027.
Read the full article here
